Friday, May 1, 2026

New Breakthrough: HER2 Positive Stomach Cancer Treatment with Dual Targeted Therapy Shows 81% Tumor Size Reduction

A study reveals that combining trastuzumab deruxtecan and pertuzumab significantly reduces tumor size in HER2-positive gastric cancer.

K-Defense Goes Global: South Korea Unveils Unified Pavilion at IDEX 2025

South Korea's DAPA will debut an "Integrated Korea Pavilion" at IDEX 2025, uniting government and SMEs for joint defense marketing.

Putin’s North Korean Gambit: Bolstering Ties as Ukraine War Drags On

Upon announcing Russian President Vladimir Putin's visit...

Tag: Ophthaviz

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

Samsung Bioepis Taps Harrow to Take Over U.S. Ophthalmic Drug Rights from Biogen

Samsung Bioepis partners with Harrow to sell ophthalmic treatments in the U.S., transferring rights from Biogen by 2025.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.